{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:18:06Z","timestamp":1778505486463,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","award":["52D\/1640"],"award-info":[{"award-number":["52D\/1640"]}],"id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.micpath.2020.104386","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T02:17:44Z","timestamp":1594433864000},"page":"104386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis"],"prefix":"10.1016","volume":"147","author":[{"given":"Hamidreza","family":"Majidiani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolhossein","family":"Dalimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Pirestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-2876","authenticated-orcid":false,"given":"Ali Dalir","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.micpath.2020.104386_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vetpar.2004.09.005","article-title":"Toxoplasmosis\u2013A waterborne zoonosis","volume":"126","author":"Dubey","year":"2004","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","article-title":"Toxoplasma gondii infection in humans and animals in the United States","volume":"38 11","author":"Dubey","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4315\/0362-028X.JFP-11-417","article-title":"Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens","volume":"75 7","author":"Hoffmann","year":"2012","journal-title":"J. Food Protect."},{"key":"10.1016\/j.micpath.2020.104386_bib4","first-page":"1","article-title":"Cats and Toxoplasma gondii: a systematic review and meta-analysis in Iran","volume":"82 1","author":"Rahimi","year":"2015","journal-title":"Onderstepoort J. Vet. Res."},{"key":"10.1016\/j.micpath.2020.104386_bib5","first-page":"189","article-title":"Rolling up the pieces of a puzzle: a systematic review and meta-analysis of the prevalence of toxoplasmosis in Iran","volume":"54 3","author":"Foroutan","year":"2017","journal-title":"Alex. J. Med."},{"key":"10.1016\/j.micpath.2020.104386_bib6","article-title":"Toxoplasma gondii: Are there any implications for routine blood screening","volume":"5 1","author":"Foroutan","year":"2017","journal-title":"Int. J. Infect."},{"key":"10.1016\/j.micpath.2020.104386_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.actatropica.2016.03.003","article-title":"Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis","volume":"158","author":"Foroutan-Rad","year":"2016","journal-title":"Acta Trop."},{"key":"10.1016\/j.micpath.2020.104386_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tmrv.2016.03.002","article-title":"Toxoplasmosis in blood donors: A systematic review and meta-analysis","volume":"30 3","author":"Foroutan-Rad","year":"2016","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.micpath.2020.104386_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: A history of clinical observations","volume":"39 8","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-014-4176-2","article-title":"Toxoplasma gondii infection among sheep and goats in Iran: A systematic review and meta-analysis","volume":"114 1","author":"Sharif","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2020.104386_bib11","article-title":"Investigating the determinants of Toxoplasma gondii prevalence in meat: A systematic review and meta-regression","volume":"11 4","author":"Belluco","year":"2016","journal-title":"PLos One"},{"key":"10.1016\/j.micpath.2020.104386_bib12","first-page":"389","article-title":"Toxoplasma gondii infection in immunocompromised patients: A systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2020.104386_bib13","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","article-title":"Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: A systematic review and meta-analysis","volume":"4 4","author":"Wang","year":"2017","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.micpath.2020.104386_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1654\/1525-2647-83.1.11","article-title":"Relationship between cat contact and infection by Toxoplasma gondii in humans: A meta-analysis","volume":"83 1","author":"Wei","year":"2016","journal-title":"Comp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopha.2016.05.041","article-title":"Human toxoplasmosis\u2013Searching for novel chemotherapeutics","volume":"82","author":"Antczak","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2020.104386_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8 6","author":"Kur","year":"2009","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00436-015-4824-1","article-title":"Review on the identification and role of Toxoplasma gondii antigenic epitopes","volume":"115 2","author":"Wang","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2020.104386_bib18","first-page":"606","article-title":"Structure of the immunodominant surface antigen from the Toxoplasma gondii SRS superfamily","volume":"9 8","author":"He","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.micpath.2020.104386_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpara.2003.12.004","article-title":"The SRS superfamily of Toxoplasma surface proteins","volume":"34 3","author":"Jung","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0020-7519(01)00261-2","article-title":"Surface antigens of Toxoplasma gondii: Variations on a theme","volume":"31 12","author":"Lekutis","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib21","series-title":"Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii","first-page":"180","volume":"71","author":"Wang","year":"2014"},{"key":"10.1016\/j.micpath.2020.104386_bib22","doi-asserted-by":"crossref","first-page":"101414","DOI":"10.1016\/j.cimid.2020.101414","article-title":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: A systematic review","author":"Pagheh","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104386_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.pt.2010.06.004","article-title":"Immunogenetics of Toxoplasma gondii informs vaccine design","volume":"26 11","author":"Henriquez","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib24","series-title":"Protein Identification and Analysis Tools on the ExPASy Server. The Proteomics Protocols Handbook","first-page":"571","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.micpath.2020.104386_bib25","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26 23","author":"Magnan","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2020.104386_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8 1","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2020.104386_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34 suppl_2","author":"Saha","year":"2006","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.micpath.2020.104386_bib28","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: Accurate sequence-based prediction of protein solubility","volume":"25 17","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2020.104386_bib29","first-page":"319","article-title":"Bioinformatics analysis and expression of a novel protein ROP48 in Toxoplasma gondii","volume":"61 2","author":"Zhou","year":"2016","journal-title":"Acta Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"Garnier","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.micpath.2020.104386_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7774\/cevr.2016.5.1.41","article-title":"In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate","volume":"5 1","author":"Fahimi","year":"2016","journal-title":"Clinic. Experim. Vacc. Res."},{"key":"10.1016\/j.micpath.2020.104386_bib32","doi-asserted-by":"crossref","first-page":"W230","DOI":"10.1093\/nar\/gki412","article-title":"DiANNA: a web server for disulfide connectivity prediction","volume":"33 suppl_2","author":"Ferr\u00e8","year":"2005","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.micpath.2020.104386_bib33","first-page":"S162","article-title":"Automated comparative protein structure modeling with SWISS\u2010MODEL and Swiss\u2010PdbViewer: a historical perspective","volume":"30 S1","author":"Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"10.1016\/j.micpath.2020.104386_bib34","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41 W1","author":"Heo","year":"2013","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.micpath.2020.104386_bib35","doi-asserted-by":"crossref","first-page":"437e450","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi, psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.micpath.2020.104386_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.meegid.2018.03.007","article-title":"Excavating chikungunya genome to design B and T cell multi-epitope subunit vaccine using comprehensive immunoinformatics approach to control chikungunya infection","volume":"61","author":"Narula","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2020.104386_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B\u2010cell epitopes in an antigen using recurrent neural network","volume":"65 1","author":"Saha","year":"2006","journal-title":"Proteins Struct. Funct. Bioinf."},{"key":"10.1016\/j.micpath.2020.104386_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/20477724.2018.1446773","article-title":"Current progress of immunoinformatics approach harnessed for cellular-and antibody-dependent vaccine design","volume":"1123","author":"Kazi","year":"2018","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.micpath.2020.104386_bib39","series-title":"International Conference on Artificial Immune Systems2004","first-page":"197","article-title":"BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties","author":"Saha","year":"2004"},{"key":"10.1016\/j.micpath.2020.104386_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9 1","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2020.104386_bib41","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.vaccine.2004.02.005","article-title":"Prediction of CTL epitopes using QM, SVM and ANN techniques","volume":"22 23\u201324","author":"Bhasin","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66 1","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.micpath.2020.104386_bib43","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3855\/jidc.4796","article-title":"Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis","volume":"8 12","author":"Ahmadpour","year":"2014","journal-title":"J. Infect. Develop. Count."},{"key":"10.1016\/j.micpath.2020.104386_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104 2","author":"Jongert","year":"2009","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.micpath.2020.104386_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pim.12177","article-title":"Immunity to Toxoplasma gondii\u2013into the 21st century","volume":"37 3","author":"Coombes","year":"2015","journal-title":"Para. Immunol."},{"key":"10.1016\/j.micpath.2020.104386_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146 1","author":"Gazzinelli","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2020.104386_bib47","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.90.13.6115","article-title":"Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts","volume":"90 13","author":"Gazzinelli","year":"1993","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2020.104386_bib48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1126\/science.161.3843.804","article-title":"Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii)","volume":"161 3843","author":"Remington","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104386_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2019.05.083","article-title":"Vaccination challenges and strategies against long-lived Toxoplasma gondii","author":"Loh","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micpath.2020.104386_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Zhang","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib51","series-title":"Toxoplasma gondii: the Model Apicomplexan. Perspectives and Methods","author":"Weiss","year":"2011"},{"key":"10.1016\/j.micpath.2020.104386_bib52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0034-5288(94)90135-X","article-title":"Western blot analysis of the IgG response of sheep vaccinated with S48 Toxoplasma gondii (Toxovax)","volume":"57 3","author":"Wastling","year":"1994","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.micpath.2020.104386_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00053","article-title":"A one health approach to vaccines against Toxoplasma gondii","author":"Innes","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib54","unstructured":"Cong H: Towards an immunosense vaccine to prevent toxoplasmosis. In: Front Immunol Conference Abstract: 15th International Congress of Immunology (ICI) doi: 103389\/conf_fimmu2013."},{"key":"10.1016\/j.micpath.2020.104386_bib55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: a mini-review","volume":"6 2","author":"Hajissa","year":"2019","journal-title":"J. Adv. Vet. Anim. Res."},{"key":"10.1016\/j.micpath.2020.104386_bib56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0264-410X(02)00566-2","article-title":"Two years into reverse vaccinology","volume":"21 7\u20138","author":"Adu-Bobie","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib57","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.vaccine.2014.06.089","article-title":"Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach","volume":"32 39","author":"Caro-Gomez","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib58","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1039\/C5MB00745C","article-title":"Identification of epitope-based peptide vaccine candidates against enterotoxigenic Escherichia coli: a comparative genomics and immunoinformatics approach","volume":"12 3","author":"Mehla","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.micpath.2020.104386_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.meegid.2019.04.017","article-title":"Bioinformatics analysis of EgA31 and EgG1Y162 proteins for designing a multi-epitope vaccine against Echinococcus granulosus","volume":"73","author":"Zhao","year":"2019","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2020.104386_bib60","article-title":"Immunogenicity and antigen structure","volume":"235","author":"Berzofsky","year":"1993","journal-title":"Fund. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2020.104386_bib61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1756-0500-2-111","article-title":"A comprehensive resource for integrating and displaying protein post-translational modifications","volume":"2","author":"Lee","year":"2009","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.micpath.2020.104386_bib62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12639-018-0996-9","article-title":"Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii","volume":"42 2","author":"Shaddel","year":"2018","journal-title":"J. Parasit. Dis."},{"issue":"17","key":"10.1016\/j.micpath.2020.104386_bib63","first-page":"1","article-title":"Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii","volume":"23","author":"Zhou","year":"2016","journal-title":"Parasite"},{"key":"10.1016\/j.micpath.2020.104386_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.vetpar.2011.02.008","article-title":"Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen","volume":"179 1\u20133","author":"Qu","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib65","first-page":"17","article-title":"T-cell immunity in human chronic toxoplasmosis","volume":"41 1","author":"El-Kady","year":"2011","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib66","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240 4851","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.micpath.2020.104386_bib67","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0020-7519(01)00261-2","article-title":"Surface antigens of Toxoplasma gondii: variations on a theme","volume":"31 12","author":"Lekutis","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib68","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1016\/j.vaccine.2015.10.077","article-title":"Toxoplasma gondii: vaccination with a DNA vaccine encoding T-and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice","volume":"33 48","author":"Cao","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib69","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.vaccine.2008.04.046","article-title":"Multi-epitope DNA vaccine linked to the A2\/B subunit of cholera toxin protect mice against Toxoplasma gondii","volume":"26 31","author":"Cong","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2020.104386_bib70","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exppara.2006.02.005","article-title":"Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model","volume":"114 1","author":"Siachoque","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib71","first-page":"215","article-title":"Immunogenicity of multiepitope vaccine candidate against Toxoplasma gondii infection in BALB\/c mice","volume":"13 2","author":"Hajissa","year":"2018","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2020.104386_bib72","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1016\/j.vaccine.2018.08.068","article-title":"Characterization of a multi-epitope peptide with selective MHC-binding capabilities encapsulated in PLGA nanoparticles as a novel vaccine candidate against Toxoplasma gondii infection","volume":"36 41","author":"Roozbehani","year":"2018","journal-title":"Vaccine"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102030752X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102030752X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:06:47Z","timestamp":1778504807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102030752X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":72,"alternative-id":["S088240102030752X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104386","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104386"}}